These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 2514157)
1. Serial allometric factor extrapolation: compartmental and physiological pharmacokinetic approaches. Hill TA; Wands RC Health Phys; 1989; 57 Suppl 1():395-401. PubMed ID: 2514157 [TBL] [Abstract][Full Text] [Related]
2. Allometric principles for interspecies extrapolation in toxicological risk assessment--empirical investigations. Schneider K; Oltmanns J; Hassauer M Regul Toxicol Pharmacol; 2004 Jun; 39(3):334-47. PubMed ID: 15135212 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI-921, a new analogue, in mice, rats, rabbits, dogs, and humans. Paxton JW; Kim SN; Whitfield LR Cancer Res; 1990 May; 50(9):2692-7. PubMed ID: 2328494 [TBL] [Abstract][Full Text] [Related]
4. Interspecies extrapolation: a reexamination of acute toxicity data. Watanabe K; Bois FY; Zeise L Risk Anal; 1992 Jun; 12(2):301-10. PubMed ID: 1502377 [TBL] [Abstract][Full Text] [Related]
5. Extrapolation of animal toxicity data to man. Vocci F; Farber T Regul Toxicol Pharmacol; 1988 Dec; 8(4):389-98. PubMed ID: 3222480 [TBL] [Abstract][Full Text] [Related]
6. The allometric approach for interspecies scaling of pharmacokinetics and toxicity of anti-cancer drugs. Paxton JW Clin Exp Pharmacol Physiol; 1995 Nov; 22(11):851-4. PubMed ID: 8593743 [TBL] [Abstract][Full Text] [Related]
7. Interspecies scaling and comparisons in drug development and toxicokinetics. Ings RM Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215 [TBL] [Abstract][Full Text] [Related]
8. In Vivo Hypoglycemic Studies of Polyherbal Phytoceuticals, Their Pharmacokinetic Studies and Dose Extrapolation by Allometric Scaling. De B; Bhandari K; Katakam P; Mitra A Curr Drug Discov Technol; 2017; 14(4):277-292. PubMed ID: 28359233 [TBL] [Abstract][Full Text] [Related]
9. Interspecies scaling of interferon disposition and comparison of allometric scaling with concentration-time transformations. Lave T; Levet-Trafit B; Schmitt-Hoffmann AH; Morgenroth B; Richter W; Chou RC J Pharm Sci; 1995 Nov; 84(11):1285-90. PubMed ID: 8587044 [TBL] [Abstract][Full Text] [Related]
10. An interspecies extrapolation of the pharmacokinetics of telavancin, a rapidly bactericidal, concentration-dependent antibiotic. Shaw JP; Jaw-Tsai S Xenobiotica; 2011 Jan; 41(1):82-9. PubMed ID: 20946087 [TBL] [Abstract][Full Text] [Related]
11. Interspecies scaling of maximum tolerated dose of anticancer drugs: relevance to starting dose for phase I clinical trials. Mahmood I Am J Ther; 2001; 8(2):109-16. PubMed ID: 11304664 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic allometric scaling of antibodies: application to the first-in-human dose estimation. Mahmood I J Pharm Sci; 2009 Oct; 98(10):3850-61. PubMed ID: 19177515 [TBL] [Abstract][Full Text] [Related]
13. Prediction of human pharmacokinetics of activated recombinant factor VII and B-domain truncated factor VIII from animal population pharmacokinetic models of haemophilia. Larsen MS; Juul RV; Groth AV; Simonsson USH; Kristensen AT; Knudsen T; Agersø H; Kreilgaard M Eur J Pharm Sci; 2018 Mar; 115():196-203. PubMed ID: 29369801 [TBL] [Abstract][Full Text] [Related]
14. Application of preclinical data to initiate the modified continual reassessment method for maximum tolerated dose-finding trials. Mahmood I J Clin Pharmacol; 2001 Jan; 41(1):19-24. PubMed ID: 11144990 [TBL] [Abstract][Full Text] [Related]
15. Interspecies scaling of a camptothecin analogue: human predictions for intravenous topotecan using animal data. Ahlawat P; Srinivas NR Xenobiotica; 2008 Nov; 38(11):1377-85. PubMed ID: 18946781 [TBL] [Abstract][Full Text] [Related]
16. [Interspecies allometric scaling in pharmacokinetics of drugs]. Sylvia M Acta Pharm Hung; 1998 Nov; 68(6):350-4. PubMed ID: 9987199 [TBL] [Abstract][Full Text] [Related]